Expert Recommendations on Balancing the Risk and Mitigation Strategies of Veno-occlusive Disease When Treating Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia with Inotuzumab Ozogamicin▼ - European Medical Journal

Continue

Expert Recommendations on Balancing the Risk and Mitigation Strategies of Veno-occlusive Disease When Treating Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia with Inotuzumab Ozogamicin▼

Hematology

This content is currently under review

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.